Matches 1 - 50 out of 125 1 2 3 >


Match Document Document Title
US20150231176 Compositions and Methods for the Treatment of Cancers  
The present invention provides a formulation comprising dichloroacetate and arsenic trioxide. The present invention also provides a method of treating cancer by administering a therapeutically...
US20110311648 Novel Methods for the Treatment of Cancer  
Compositions and methods for the treatment of malignancy and chronic viral infection are disclosed.
US20120251628 COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER  
Compositions and methods for treating solid tumors are provided. Intraperitoneal administration of sodium meta arsenite, alone or in combination with an anti-cancer agent, results in tumor...
US20140271729 USE OF BIOGENIC AMINES SPERMINE AND SPERMIDINE FOR THE HOMEOPATHIC TREATMENT OF HORMONE IMBALANCES  
This invention relates to a composition, and methods of administration and treatment comprising a homeopathic preparation of an effective amount of Spermine and/or Spermidine that improves hormone...
US20130344083 MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER  
Provided are methods and compositions for treatment of cancer. In particular, these methods and compositions may include an inhibitor of a deubiquitinating enzyme. In certain aspects, these...
US20130287791 MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER  
Provided are methods and compositions for treatment of cancer. In particular, these methods and compositions may include an inhibitor of a deubiquitinating enzyme. In certain aspects, these...
US20120045519 USE OF DEOXYELEPHANTOPIN (DET) AND ANALOGUES THEREOF FOR TREATMENT OF MELANOMA  
Methods for treating melanoma in a subject in need thereof are disclosed. The method comprises administering to the subject a composition comprising a therapeutically effective amount of...
US20100278937 COMPOSITIONS AND METHODS TO PREVENT AND/OR TREAT CANCER WITH PA-CARD  
The present invention relates to methods and materials for killing cancer cells with proteins derived from bacteria. The invention specifically relates to Azurin, Laz, Pa-CARD, and fusion proteins...
US20130309319 USE OF ARSENIC COMPOUNDS FOR TREATMENT OF PAIN AND INFLAMMATION  
The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO2), arsenic trioxide (As2O3), and arsenic hexoxide (As4O6) or combinations thereof, for the...
US20120027871 METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE  
The invention provides methods for the administration of compounds capable of prolonging a QTc interval and methods for predicting whether an individual is predisposed to such QTc prolongation.
US20120058201 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION  
The present invention describes an association between genetic polymorphisms in the FAM13A1 (family with sequence similarity 13, member A1) gene and a predisposition to prolongation of the QT...
US20140242190 USE OF DEOXYELEPHANTOPIN (DET) AND ANALOGUES THEREOF FOR TREATMENT OF MELANOMA  
Methods for preventing and/or reducing side effects of an anti-cancer agent in a subject in need thereof are disclosed. The method comprises administering to the subject, who is under an...
US20110244027 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods of Treating Viral Infections  
The present invention relates to 2′-Fluoro-6′-methylene carbocyclic nucleosides, pharmaceutical compositions containing these nucleosides and their use in the treatment or prophylaxis of a number...
US20110059186 CANCER STEM CELL-TARGETED AND DRUG RESISTANT CANCER THERAPY  
The present invention provides methods for preventing, treating, and/or managing cancer, the method comprising administering to a subject in need thereof therapeutically effective amount of sodium...
US20110250291 USE OF ARSENIC FOR CANCER THERAPY PROTECTION  
A method of inhibiting damage to non-cancerous cells in a human subject during chemotherapeutic treatment or radiation treatment of cancer cells in the human subject includes administering to the...
US20140220154 METHOD OF TREATING PATHOLOGIC HETEROTOPIC OSSIFICATION  
What is described is a method of preventing or treating heterotopic ossification, vascular calcification, and pathologic mineralization, comprising administering an drug, wherein the drug is an...
US20120294955 USE OF ARSENIC FOR CANCER THERAPY PROTECTION  
A method of inhibiting, preventing, or reducing damage to non-cancerous cells in a human subject during chemotherapeutic treatment or radiation treatment of cancer cells in the human subject...
US20110020434 NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS  
The present invention relates to nanoparticle encapsulated arsenic and platinum compositions and methods of use thereof. In particular, the present invention provides co-encapsulation of active...
US20150209379 TREATMENT OF PROSTATE CANCER AND HEMATOLOGIC NEOPLASMS  
Prostate cancer and hematological neoplasms are treated by administration of (i) a compound of Formula I: wherein: R1 is —OH or —O—P(O)(OH)2; and R2 is (II) or (III); (ii) N6-benzyladenosine,...
US20110091573 PROCESS FOR PRODUCING ARSENIC TRIOXIDE FORMULATIONS AND METHODS FOR TREATING CANCER USING ARSENIC TRIOXIDE OR MELARSOPROL  
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic...
US20150024065 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS  
Activation of HIV-1 replication causes oxidative stress, which in turn potentiates HIV-1 replication. The common basis for the compounds of the present invention is: A) the capacity of...
US20110305774 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS  
Activation of HIV-1 replication causes oxidative stress, which in turn potentiates HIV-1 replication. The common basis for the compounds of the present invention is: A) the capacity of...
US20110070314 METHODS FOR TREATING BRAIN TUMORS  
The present invention relates to methods treating brain tumors comprising administering a subject in need thereof a therapeutically effective amount of sodium meta arsenite, alone or in...
US20110206756 DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF  
Described herein are compositions useful in anticancer treatment and prevention. The compositions are composed of (a) a dithiocarbamate metal chelate and (b) an amphiphile, wherein the amount of...
US20120045520 PHARMACEUTICAL COMPOSITION COMPRISING ARSENITE FOR THE TREATMENT OF MALIGNANCY  
A method for using a salt of meta-arsenite (AsO2—) to suppress growing of human cancer cells is provided to find a method of curing human cancers. Effects of the salt of meta-arsenite (AsO2—) on...
US20150110713 METHOD AND COMPOSITION FOR TREATING CANCER  
A method for treating cancer, preventing cancer or delaying the progression of a cancer in an animal or human comprising the step of: administering to the animal or the human having a cancer a...
US20120164065 METHOD AND COMPOSITION FOR TREATING CANCER  
A method for treating cancer, preventing cancer or delaying the progression of a cancer in an animal or human comprising the step of: administering to the animal or the human having a cancer a...
US20110195110 UREA COMPOUNDS USEFUL IN THE TREATMENT OF CANCER  
Pyrazole urea compounds, pharmaceutical compositions which contain them and methods for treating cancer using them.
US20140017336 CO-ADMINISTRATION OF ARSENIC COMPOUNDS AND ANTI-HERPES VIRUS ANTI-VIRALS  
It has now been discovered that arsenic induces herpes viruses latent in infected cells to reactivate to the lytic stage. Herpes viruses in the lytic stage activate anti-herpes virus anti viral...
US20120128791 Ammoniacal Copper Zinc Arsenate Concentrates and Methods of Preparation  
Disclosed herein is a composition concentrate that is suitable for treating wood upon dilution with water in a weight ratio of concentrate to water of between 1:10 and 1:100. The concentrate...
US20090098216 ARSENIC THERAPY FOR APLS-TYPE AUTOIMMUNE LYMPH-OPROLIFERATIVE SYNDROME IN MICE AND HUMANS  
The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
US20140370119 Arsenic Compound Solution and Albumin Nanoparticle and Lyophilized Preparation Entrapping Arsenic Compound Prepared Using Same  
An arsenic compound solution, and an albumin nanoparticle and a lyophilized preparation prepared using same and entrapping an arsenic compound. The arsenic compound solution is prepared using the...
US20110250292 COMPOSITION FOR IMPROVING RADIOTHERAPY FOR CANCER  
Disclosed is a composition for improving radiotherapy for cancer, containing tetra-arsenic oxide (As4O6) as an active ingredient. The disclosed composition for improving radiotherapy for cancer...
US20110200684 SYNERGISTIC PESTICIDAL MIXTURES  
Synergistic pesticidal mixtures are provided.
US20090297624 ARSENIC THERAPY FOR AUTOIMMUNE AND/OR INFLAMMATORY DISEASES IN MICE AND HUMANS  
The invention relates to a method for treating and/or preventing autoimmune and/or inflammatory diseases, including the graft-versus-host disease, comprising administering to a patient in need...
US20080193560 Use of arsenic compounds for treatment of pain and inflammation  
The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO2), arsenic trioxide (As2O3), and arsenic hexoxide (As4O6) or combinations thereof, for the...
US20110256236 Enhancement of the Anti-Leukemic Effect of Thalidomide  
The cytotoxic effects of thalidomide are enhanced when it is used in combination with other chemotherapeutic agents, particularly arsenic trioxide, indicating benefits for the treatment of...
US20050058722 Herbo-mineral formulation for refractory leukemias and lymphomas  
A pharmaceutical or medicinal preparation comprising a mixture of arsenic trioxide (As2O3) and the herbs Aloe Vera (Aloe Barbedensis), Withania Somnifera, Glycine Max, Rubia Cordifolia and Acacia...
US20130230542 ROS-Activated Compounds as Selective Anti-Cancer Therapeutics  
Provided are compounds according to the following Formula I: The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer...
US20070249647 Substituted CIS- and trans-stilbenes as therapeutic agents  
The present invention relates to method(s) of treating a subject afflicted with cancer or a precancerous condition, an inflammatory disease or condition, and/or stroke or other ischemic disease or...
US20080279961 TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS  
It is demonstrated in the present invention that G-quadruplex ligands can be used to both shorten telomeres and inhibit telomerase by causing telomere uncapping. The invention relates to...
US20060292243 Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases  
A method of treatments for arsenic-sensitive blast-cell related diseases comprising administering a therapeutically effective amount of arsenic compounds to a human or an animal.
US20100260864 TREATMENT OR PREVENTION OF CANCER AND PRECANCEROUS DISORDERS  
The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS),...
US20100291234 COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY ARTHRITIS  
Methods for treating or preventing one or more symptoms of rheumatoid arthritis or other types of inflammatory arthritis involves administering a formulation containing an effective amount of...
US20120195890 OLIGONUCLEOTIDES INHIBITING CELLULAR MIGRATION  
Oligonucleotides inhibiting cellular migration, and the use of at least one inhibitor of protein expression, which inhibits the expression of TSP1 protein, or a protein, which controls the...
US20120093917 METNASE AND INTNASE INHIBITORS AND THEIR USE IN TREATING CANCER  
This invention relates to novel cancer treatment compositions and associated therapeutic methods. More particularly, this invention relates in part to small chemical inhibitors of DNA repair...
US20060275504 Methods and compositions for augmenting cancer chemotherapeutic agents  
This invention provides methods and pharmaceutical compositions/therapy combination product for cancer treatment and/or augmenting the effectiveness of cancer chemotherapeutic agents by use of a...
US20140072529 SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE SALTS  
The present invention relates:—to 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro imidazo-[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (II): or a...
US20050208149 Use of arsenic-containing pharmaceutical composition in combination with radiation therapy for cancer treatment  
The present invention discloses the combination use of arsenic-containing pharmaceutical composition and radiation therapy on cutaneous metastases.
US20100104628 METHOD OF TREATING NEUROBLASTOMA  
The present invention relates, in general, to neuroblastoma and, in particular, to a method of treating neuroblastoma tumors, including refractory neuroblastoma tumors. The invention also relates...

Matches 1 - 50 out of 125 1 2 3 >